Sequent Scientific zooms with arm receiving EU GMP approval for Turkey manufacturing unit

02 Aug 2018 Evaluate

Sequent Scientific is currently trading at Rs. 57.75, up by 6.15 points or 11.92% from its previous closing of Rs. 51.60 on the BSE.

The scrip opened at Rs. 52.40 and has touched a high and low of Rs. 61.70 and Rs. 52.40 respectively. So far 143455 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 127.51 on 21-Sep-2017 and a 52 week low of Rs. 44.65 on 05-Jun-2018.

Last one week high and low of the scrip stood at Rs. 61.70 and Rs. 50.10 respectively. The current market cap of the company is Rs. 1395.39 crore.

The promoters holding in the company stood at 57.28%, while Institutions and Non-Institutions held 17.23% and 25.49% respectively.

Sequent Scientific’s subsidiary -- Alivira Animal Health -- has received EU GMP approval from Bulgarian authority's for its manufacturing unit in Ankara, Turkey.  With this approval, Alivira now has 4 EU GMP certified manufacturing units, with one each in Turkey, Spain, Germany and India.

Sequent Scientific is an integrated pharmaceutical company with a global footprint headquartered in Bangalore, India which has presence in different pharmaceutical verticals including APIs, Animal Health, Analytical Services, CRAMS and specialty chemicals. Sequent is the world's largest producer of Anthelmintics and by far the strongest player in the Veterinary API business.

Viyash Scientific Share Price

198.65 4.55 (2.34%)
22-Jan-2026 13:57 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1617.70
Dr. Reddys Lab 1217.20
Cipla 1372.40
Zydus Lifesciences 884.50
Lupin 2172.65
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×